| 0301.99.01 | 10 | Tench (Tinca tinca), sheatfish (Silurus glanis) | X | | | |
| 0505.10.00 | 50 | Meeting both test standards 4 and 10.1 of Federal Standard 148a promulgated by the General Services Administration: | | | | |
| 0909 | | Seeds of anise, badian, fennel, coriander, cumin or caraway; juniper berries: | | | | |
| 0909.10.00 | 00 | Seeds of anise or badian | kg | Free | | Free |
| 2102 | | Yeasts (active or inactive); other single-cell microorganisms, dead (but not including vaccines of heading 3002); prepared baking powders: | | | | |
| 2102.20 | | Inactive yeasts; other single-cell microorganisms, dead: | | | | |
| 2909.30.05 | 00 | 5-Chloro-2-nitroanisole; 6-Chloro-3-nitro-p-dimethoxybenzene; and Dimethyl diphenyl ether | kg | 5.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 40% |
| 2909.30.10 | 00 | 6-tert-Butyl-3-methyl-2,4-dinitroanisole (Musk ambrette) and other artificial musks | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 57% |
| 2912.49.10 | 00 | p-Anisaldehyde | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 36% |
| 2918.99.05 | 00 | p-Anisic acid; Clofibrate; 1,6-Hexanediol bis(3,5-dibutyl-4-hydroxy- phenyl)propionate; and 3-Phenoxybenzoic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 40% |
| 2922.29.03 | 00 | o-Anisidine; p-Anisidine; and p-Phenetidine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4￠/kg + 65% |
| 2922.29.06 | 00 | m-Nitro-p-anisidine; and m-Nitro-o-anisidine: | | | | |
| 2922.29.10 | 00 | 2-Amino-6-chloro-4-nitrophenol; 2-Amino-4-chlorophenol; 2-Amino-4-chlorophenol hydrochloride; 2-Amino-p-cresol; 4-Amino-o-cresol; 6-Amino-2,4-dichloro-3-methylphenol; 2-(3-Amino-4-hydroxyphenylsulfonyl)ethanol; 2-Amino-4-nitrophenol; 2-Amino-4-nitrophenol, sodium salt; 2-Amino-5-nitrophenol; m-Aminophenol; 2-(4'-Aminophenoxy)ethylsulfate; 5-Chloro-2-(2',4'-dichlorophenoxy)aniline; 3,4-Dimethoxyphenethylamine (Homoveratrylamine); 2-Hydroxy-5-nitrometanilic acid; 4-Methoxymetanilic acid; 6-Methoxymetanilic acid; 4-Methoxy-m-phenylenediamine; 5-Methoxy-m-phenylenediamine sulfate; 6-(Methylamino)-1-naphthol-3-sulfonic acid; 7-(Methylamino)-1-naphthol-3-sulfonic acid; and 2-Methyl-p-anisidine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.29.81 | 10 | p-Nitro-o-anisidine | kg | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.29.01 | 00 | p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamide | kg | Free | | 15.4￠/kg + 39.5% |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 53% |
| 2924.29.33 | 00 | 3-Hydroxy-2-naphthanilide; 3-Hydroxy-2-naphtho-o-toluidide; 3-Hydroxy-2-naphtho-o-anisidine; 3-Hydroxy-2-naphtho-o-phenetidide; 3-Hydroxy-2-naphtho-4-chloro-2,5- dimethoxyanilide; 3-Hydroxy-3'-nitro-2-naphthanilide; and N,N'-Bis(acetoacetyl-o-toluidine) | kg | Free | | 15.4￠/kg + 60% |
| 2937.21.00 | | Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) | | Free | | 25% |
| 2937.21.00 | 30 | Prednisone | g | | | |
| 2937.21.00 | 40 | Prednisolone | g | | | |
| 2937.29.90 | 30 | Salts and esters of prednisone | g | | | |
| 2937.29.90 | 40 | Salts and esters of prednisolone | g | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
